Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Stratton

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
BMJ Open|November 21, 2012
Geographical variation in certification rates of blindness and sight impairment in England, 2008-2009Aeesha N J Malik, Catey Bunce, Richard Wormald, et al.
Trials|June 20, 2022
Protocol paper: multi-Centre randomised controlled trial evaluating a pre-clinic diabetes assessment and mapped care planning intervention amongst adults with type 1, type 2 or pre-diabetesRyan Charles Kelly, Peter Phiri, Hermione Price, et al.
JAMA Ophthalmology|November 19, 2020
Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationDun Jack Fu, Tiarnan D Keenan, Livia Faes, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
BMJ Open|November 21, 2012
Geographical variation in certification rates of blindness and sight impairment in England, 2008-2009Aeesha N J Malik, Catey Bunce, Richard Wormald, et al.
Trials|June 20, 2022
Protocol paper: multi-Centre randomised controlled trial evaluating a pre-clinic diabetes assessment and mapped care planning intervention amongst adults with type 1, type 2 or pre-diabetesRyan Charles Kelly, Peter Phiri, Hermione Price, et al.
JAMA Ophthalmology|November 19, 2020
Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationDun Jack Fu, Tiarnan D Keenan, Livia Faes, et al.
Pageof 2